Baxter

Medical Equipment
BAX
$ 74 0.9
Share price
$ 37 bn
Market Cap
$ 51 bn
Enterprise Value

Carbon footprint

12 Ton
GHG emissions per $ 1 mln investment
0.42x the weighted average for S&P 500
FY2020
How is this calculated?
+1.7%
YOY change in GHG emissions
Weaker than the -8.7% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

-2.5%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -5.1% weighted average for S&P 500
FY2021
How is this calculated?

Baxter aims to reduce Scope 1 + 2 by 25% by 2030 from a base year 2020


This target has not been verified as science based according to SBTi
Baxter's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Baxter's GHG emissions (market-based) (Kt of CO2e)
Baxter's Carbon intensity (Tons per 1 USDm)

Baxter's carbon footprint

Baxter reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 611 Kt (+10/+1.7% y-o-y). At the sime time, carbon intensity decreased to 52 t (-0.6 /-1.1% y-o-y).

Baxter's Scope 3 emissions declined to 3,882 Kt (-371 /-8.7% y-o-y). The decline accelerated compared to the CAGR of -5.5% since 4Q'18.

The company is committed to reducing Scope 1 + 2 by 25% by 2030 from a base year 2020, which translates into the estimated reduction of -15 Kt per annum over the period of FY2021 - FY2030. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Company environmental metrics

Show more...
Copyright © 2022 Exerica. All rights reserved.